GB824337A - Therapeutic compositions - Google Patents
Therapeutic compositionsInfo
- Publication number
- GB824337A GB824337A GB24071/56A GB2407156A GB824337A GB 824337 A GB824337 A GB 824337A GB 24071/56 A GB24071/56 A GB 24071/56A GB 2407156 A GB2407156 A GB 2407156A GB 824337 A GB824337 A GB 824337A
- Authority
- GB
- United Kingdom
- Prior art keywords
- resin
- cross
- linked
- cation exchange
- sulphonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 230000001225 therapeutic effect Effects 0.000 title 1
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 abstract 8
- 239000011347 resin Substances 0.000 abstract 8
- 229920005989 resin Polymers 0.000 abstract 8
- 150000001412 amines Chemical class 0.000 abstract 6
- 239000003729 cation exchange resin Substances 0.000 abstract 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 4
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229960000582 mepyramine Drugs 0.000 abstract 3
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 abstract 3
- 239000002245 particle Substances 0.000 abstract 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 abstract 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- UFLGIAIHIAPJJC-UHFFFAOYSA-N Tripelennamine Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 UFLGIAIHIAPJJC-UHFFFAOYSA-N 0.000 abstract 2
- 229940025084 amphetamine Drugs 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 239000002775 capsule Substances 0.000 abstract 2
- 229940023913 cation exchange resins Drugs 0.000 abstract 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 abstract 2
- 230000003111 delayed effect Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000000839 emulsion Substances 0.000 abstract 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 239000006187 pill Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 150000003440 styrenes Chemical class 0.000 abstract 2
- 239000006188 syrup Substances 0.000 abstract 2
- 235000020357 syrup Nutrition 0.000 abstract 2
- 229960003223 tripelennamine Drugs 0.000 abstract 2
- 229920002554 vinyl polymer Polymers 0.000 abstract 2
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 abstract 1
- ZOWYFYXTIWQBEP-UHFFFAOYSA-N 1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxyisoquinoline Chemical compound C1=C(OCC)C(OCC)=CC=C1CC1=NC=CC2=CC(OCC)=C(OCC)C=C12 ZOWYFYXTIWQBEP-UHFFFAOYSA-N 0.000 abstract 1
- NARHAGIVSFTMIG-UHFFFAOYSA-N 4-(dimethylamino)-2,2-diphenylpentanamide Chemical compound C=1C=CC=CC=1C(C(N)=O)(CC(C)N(C)C)C1=CC=CC=C1 NARHAGIVSFTMIG-UHFFFAOYSA-N 0.000 abstract 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 abstract 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 abstract 1
- 229930003347 Atropine Natural products 0.000 abstract 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 abstract 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 abstract 1
- GULNIHOSWFYMRN-UHFFFAOYSA-N N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-(2-pyrimidinyl)ethane-1,2-diamine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=NC=CC=N1 GULNIHOSWFYMRN-UHFFFAOYSA-N 0.000 abstract 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 abstract 1
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 abstract 1
- 241000700159 Rattus Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 abstract 1
- 229960000396 atropine Drugs 0.000 abstract 1
- 229940088007 benadryl Drugs 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- -1 chlor-trimetin Chemical compound 0.000 abstract 1
- 229950005434 chloropyrilene Drugs 0.000 abstract 1
- XAEXSWVTEJHRMH-UHFFFAOYSA-N chloropyrilene Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=C(Cl)S1 XAEXSWVTEJHRMH-UHFFFAOYSA-N 0.000 abstract 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 abstract 1
- 229960003291 chlorphenamine Drugs 0.000 abstract 1
- 229960004126 codeine Drugs 0.000 abstract 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
- RBOXVHNMENFORY-DNJOTXNNSA-N dihydrocodeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC RBOXVHNMENFORY-DNJOTXNNSA-N 0.000 abstract 1
- 229960000920 dihydrocodeine Drugs 0.000 abstract 1
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 abstract 1
- 229950001902 dimevamide Drugs 0.000 abstract 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 abstract 1
- 229960002179 ephedrine Drugs 0.000 abstract 1
- 229960005269 ethaverine Drugs 0.000 abstract 1
- 210000004051 gastric juice Anatomy 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 229950006187 hexamethonium bromide Drugs 0.000 abstract 1
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 abstract 1
- 229960000240 hydrocodone Drugs 0.000 abstract 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 abstract 1
- LZCOQTDXKCNBEE-IKIFYQGPSA-N methscopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)C)=CC=CC=C1 LZCOQTDXKCNBEE-IKIFYQGPSA-N 0.000 abstract 1
- PIPAJLPNWZMYQA-YVSFHVDLSA-N methylatropine Chemical compound C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](C2)OC(=O)[C@@H](CO)c3ccccc3 PIPAJLPNWZMYQA-YVSFHVDLSA-N 0.000 abstract 1
- 229960005096 methylatropine Drugs 0.000 abstract 1
- 229960001383 methylscopolamine Drugs 0.000 abstract 1
- NPZXCTIHHUUEEJ-CMKMFDCUSA-N metopon Chemical compound O([C@@]1(C)C(=O)CC[C@@H]23)C4=C5[C@@]13CCN(C)[C@@H]2CC5=CC=C4O NPZXCTIHHUUEEJ-CMKMFDCUSA-N 0.000 abstract 1
- 229950006080 metopon Drugs 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 229940113083 morpholine Drugs 0.000 abstract 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
- 229960002085 oxycodone Drugs 0.000 abstract 1
- 229960001789 papaverine Drugs 0.000 abstract 1
- OOBHFESNSZDWIU-UHFFFAOYSA-N phenmetrazine Chemical compound CC1NCCOC1C1=CC=CC=C1 OOBHFESNSZDWIU-UHFFFAOYSA-N 0.000 abstract 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 abstract 1
- 229960002646 scopolamine Drugs 0.000 abstract 1
- 229960003785 thonzylamine Drugs 0.000 abstract 1
- XJGONMZLEDGBRM-UHFFFAOYSA-M tridihexethyl chloride Chemical compound [Cl-].C=1C=CC=CC=1C(O)(CC[N+](CC)(CC)CC)C1CCCCC1 XJGONMZLEDGBRM-UHFFFAOYSA-M 0.000 abstract 1
- 229960004453 trimethadione Drugs 0.000 abstract 1
- FAPSXSAPXXJTOU-UHFFFAOYSA-L trimethyl-[6-(trimethylazaniumyl)hexyl]azanium;dibromide Chemical compound [Br-].[Br-].C[N+](C)(C)CCCCCC[N+](C)(C)C FAPSXSAPXXJTOU-UHFFFAOYSA-L 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE550155D BE550155A (enrdf_load_stackoverflow) | 1956-08-03 | ||
| BE525633D BE525633A (enrdf_load_stackoverflow) | 1956-08-03 |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US347942XA | 1955-08-08 | 1955-08-08 | |
| US60256XA | 1956-02-06 | 1956-02-06 | |
| US150356XA | 1956-03-15 | 1956-03-15 | |
| US30556XA | 1956-05-03 | 1956-05-03 | |
| US120756XA | 1956-07-12 | 1956-07-12 | |
| US160756XA | 1956-07-16 | 1956-07-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB824337A true GB824337A (en) | 1959-11-25 |
Family
ID=27555438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB24071/56A Expired GB824337A (en) | 1955-08-08 | 1956-08-03 | Therapeutic compositions |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE550150A (enrdf_load_stackoverflow) |
| CH (1) | CH347942A (enrdf_load_stackoverflow) |
| DE (1) | DE1045599B (enrdf_load_stackoverflow) |
| FR (1) | FR1213407A (enrdf_load_stackoverflow) |
| GB (1) | GB824337A (enrdf_load_stackoverflow) |
| MY (1) | MY6300063A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2373288A1 (fr) * | 1976-11-26 | 1978-07-07 | Pennwalt Corp | Preparation pharmaceutique a liberation prolongee |
| FR2589731A1 (fr) * | 1985-11-08 | 1987-05-15 | Covex Sa | Procede de preparation de resinates de la (-)eburnamenine-14-(15h)-one |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1110819B (de) * | 1958-11-14 | 1961-07-13 | Frank W Horner Ltd | Verfahren zum Verbessern von Adsorbaten des Penicillins an Antionenaustauscherharze |
| NL255047A (enrdf_load_stackoverflow) * | 1959-08-21 | |||
| DE1182390B (de) * | 1960-12-27 | 1964-11-26 | Dr Gustavo Damilano | Verfahren zur Herabsetzung der Resorptionsgeschwindigkeit von therapeutisch wirksamen, loeslichen Stoffen |
| JPS5762277A (en) * | 1980-06-23 | 1982-04-15 | Ciba Geigy Ag | Manufacture of effect-enduring vincamine blend, obtained vincamine blend and medicine |
| US4369175A (en) | 1981-07-27 | 1983-01-18 | Ciba-Geigy Corporation | Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them |
-
0
- BE BE550150D patent/BE550150A/xx unknown
-
1956
- 1956-08-03 GB GB24071/56A patent/GB824337A/en not_active Expired
- 1956-08-07 DE DEST11503A patent/DE1045599B/de active Pending
- 1956-08-07 FR FR1213407D patent/FR1213407A/fr not_active Expired
- 1956-08-08 CH CH347942D patent/CH347942A/de unknown
-
1963
- 1963-12-31 MY MY196363A patent/MY6300063A/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2373288A1 (fr) * | 1976-11-26 | 1978-07-07 | Pennwalt Corp | Preparation pharmaceutique a liberation prolongee |
| FR2589731A1 (fr) * | 1985-11-08 | 1987-05-15 | Covex Sa | Procede de preparation de resinates de la (-)eburnamenine-14-(15h)-one |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1045599B (de) | 1958-12-04 |
| CH347942A (de) | 1960-07-31 |
| MY6300063A (en) | 1963-12-31 |
| BE550150A (enrdf_load_stackoverflow) | |
| FR1213407A (fr) | 1960-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0368682B1 (en) | Pharmaceutical ion exchange resin composition | |
| EP0185420B1 (en) | Dihydrocodeine/ibuprofen pharmaceutical compositions and method | |
| EP0847273B1 (en) | Improved pharmaceutical ion exchange resin composition | |
| EP0108218A2 (en) | Constant release rate solid oral dosage formulation of pharmaceutical compounds having a high degree of water solubility | |
| EP2702989B1 (en) | Stable pharmaceutical composition | |
| AU676315B2 (en) | Stabilized solid pharmaceutical preparation and method of producing the same | |
| US4668684A (en) | Combination of flupirtin and anticholinergic acting spasmolytic | |
| EP0557065A1 (en) | Spheroid formulation | |
| KR890016968A (ko) | 약제 흡착물 | |
| GB1390772A (en) | Oral narcotic composition | |
| GB824337A (en) | Therapeutic compositions | |
| KR920006908B1 (ko) | 디히드로피리딘을 함유하는 고상 약제의 제조 방법 | |
| JPH0142923B2 (enrdf_load_stackoverflow) | ||
| EP1200088B1 (en) | Paracetamol and drotaverine containing composition | |
| JPH08507751A (ja) | 医薬としてのベンゾイルエクゴニン誘導体、エクゴニン誘導体、およびエクゴニジン誘導体 | |
| EP0099186B1 (en) | Pharmaceutical compositions | |
| FR561M (enrdf_load_stackoverflow) | ||
| GB2129301A (en) | Sustained release microgranules containing sulpiride | |
| US4781919A (en) | Sustained release dosage form | |
| CN104274414B (zh) | 一种甲基纳曲酮复合物、口服片剂及其制备方法 | |
| US3920806A (en) | Growth promoting subcutaneous compositions | |
| CN114073690B (zh) | 一种含有氨基酸的防提取药物组合物及其制剂 | |
| CN103768060B (zh) | 一种布洛芬、盐酸伪麻黄碱和马来酸氯苯那敏的复方片剂 | |
| CN1568951A (zh) | 一种预防和治疗急性痛风、肿瘤和肝肺纤维化的药物及其制备方法 | |
| JP3417335B2 (ja) | 複合組成物 |